Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Huggins

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Cardiac Surgery|July 1, 1995
Acute regional myocardial ischemia and recovery after cardiopulmonary bypass: effects of intensity of antecedent ischemiaB J Leone, C P Huggins, J Johns, et al.
Cephalalgia : an International Journal of Headache|December 25, 2013
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 programMarcelo E Bigal, Rafael Escandon, Michele Bronson, et al.
Journal of Fish Biology|March 28, 2022
An update on the evolutionary origin of aglomerular kidney with structural and ultrastructural descriptions of the kidney in three fish speciesSinlapachai Senarat, Jes Kettratad, Supanut Pairohakul, et al.
Psychopharmacologia|August 22, 1973
The managment of severe agoraphobia: a comparison of iproniazid and systematic desensitizationM S Lipsedge, J Hajioff, P Huggins, et al.
Contemporary Clinical Trials|February 3, 2007
Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I studyAlex Collie, Amanda Darekar, Georges Weissgerber, et al.
British Journal of Clinical Pharmacology|November 3, 2011
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGai Ling Li, Helen Winter, Rosalin Arends, et al.
European Journal of Pharmacology|May 15, 1993
Modelling and modification of the binding site of endothelin and other receptorsJ P Huggins, S Trumpp-Kallmeyer, M F Hibert, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|April 5, 2011
Identification of differentially expressed thyroid hormone responsive genes from the brain of the Mexican Axolotl (Ambystoma mexicanum)P Huggins, C K Johnson, A Schoergendorfer, et al.
Genetics|March 22, 2025
Two eIF4E paralogs occupy separate germ granule messenger ribonucleoproteins that mediate mRNA repression and translational activationGita Gajjar, Hayden P Huggins, Eun Suk Kim, et al.
Open Forum Infectious Diseases|February 6, 2024
Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal ProphylaxisJonathan P Huggins, David Arthur, Shein-Chung Chow, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cardiac Surgery|July 1, 1995
Acute regional myocardial ischemia and recovery after cardiopulmonary bypass: effects of intensity of antecedent ischemiaB J Leone, C P Huggins, J Johns, et al.
Cephalalgia : an International Journal of Headache|December 25, 2013
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 programMarcelo E Bigal, Rafael Escandon, Michele Bronson, et al.
Journal of Fish Biology|March 28, 2022
An update on the evolutionary origin of aglomerular kidney with structural and ultrastructural descriptions of the kidney in three fish speciesSinlapachai Senarat, Jes Kettratad, Supanut Pairohakul, et al.
Psychopharmacologia|August 22, 1973
The managment of severe agoraphobia: a comparison of iproniazid and systematic desensitizationM S Lipsedge, J Hajioff, P Huggins, et al.
Contemporary Clinical Trials|February 3, 2007
Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I studyAlex Collie, Amanda Darekar, Georges Weissgerber, et al.
British Journal of Clinical Pharmacology|November 3, 2011
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjectsGai Ling Li, Helen Winter, Rosalin Arends, et al.
European Journal of Pharmacology|May 15, 1993
Modelling and modification of the binding site of endothelin and other receptorsJ P Huggins, S Trumpp-Kallmeyer, M F Hibert, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|April 5, 2011
Identification of differentially expressed thyroid hormone responsive genes from the brain of the Mexican Axolotl (Ambystoma mexicanum)P Huggins, C K Johnson, A Schoergendorfer, et al.
Genetics|March 22, 2025
Two eIF4E paralogs occupy separate germ granule messenger ribonucleoproteins that mediate mRNA repression and translational activationGita Gajjar, Hayden P Huggins, Eun Suk Kim, et al.
Open Forum Infectious Diseases|February 6, 2024
Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal ProphylaxisJonathan P Huggins, David Arthur, Shein-Chung Chow, et al.
Pageof 6